This practical advanced course will comprehensively explore the ECS and its implications in patients with migraine, fibromayalgia, irritable bowel syndrome and other treatment resistant syndromes, before investigating the two major cannabinoids, tetrahydrocannabidiol (THC) and cannabidiol (CBD) to delve into their characteristics and clinical applications.
The course is presented by Dr Jim Connell, a GP that has been treating patients with cannabis medicine since 2018.
You will learn how to address real-world concerns of GPs including cannabis use disorder and stigma, and the processes and procedures surrounding medicinal cannabis prescribing in Australia as you work through case studies addressing patients with chronic pain and anxiety.